Tetanus boosters not cost-effective.
Rosser
W W
WW
D003362:Cost-Benefit Analysis; D006801:Humans; D007117:Immunization, Secondary / Q000191:economics; D010349:Patient Compliance; D017010:Reminder Systems; D013745:Tetanus Toxoid
D013745:Tetanus Toxoid